Since 2020 we have focused on mental health, in Spain but also in Europe, especially on real access problems to the public system, the use of models that do not respect human rights or the overmedication of the population. Awards:
- Accesit in the Miradas 2022 Award
- European Science Journalist of the Year 2022 Award to Ángela Bernardo
- Observable Community Recognition Award 2021 to Carmen Torrecillas
Doctors continue prescribing anti-anxiety medications such as lorazepam or diazepam for long periods despite the risk of addictions. Meanwhile, under-investment in psychological care is making things worse.
In the European Union, thousands of people with serious mental disorders live isolated and secluded from society, without receiving all the care they need. At least 150 million euros of European Union funds, intended to improve their situation, have been used for other purposes.
In many European countries, the availability of psychological treatment in the public healthcare system is inadequate or even non-existent. Barriers such as long waiting lists, co-payments and inadequate resources push people with anxiety or depression -those who can afford it- to the private system.
If you want to know more about this topic, check out all our articles on Health